I agree that this site is using cookies. You can find further informations here.
X
Orfanos, P.
382  results:
Search for persons X
?
1

Review on clinical strategies for managing patients with el..:

Orfanos, P ; Hu, X ; Montgomery, G...
European Journal of Cardiovascular Nursing.  22 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

POSA423 Healthcare Resource Utilization (HRU) Survey to Inf..:

Gandola, A ; Orfanos, P ; AIT Sarkouh, R...
Value in Health.  25 (2022)  1 - p. S272 , 2022
Link: https://doi.org/10.1016/..
 
?
3

POSC370 Health-Related Quality of Life of Naratuximab Emtas..:

Orfanos, P ; Peipert, J ; Cella, D...
Value in Health.  25 (2022)  1 - p. S245 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Adverse childhood experiences and substance misuse in young..:

Fernandes, G. S. ; Spiers, A. ; Vaidya, N....
BMC Public Health.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
5

PCN72 An EARLY Cost-Effectiveness Analysis of Xevinapant in..:

Gandola, A. ; AIT Sarkouh, R. ; Orfanos, P...
Value in Health.  24 (2021)  - p. S32 , 2021
Link: https://doi.org/10.1016/..
 
?
6

P370 Concomitant azathioprine prevents new-onset arthralgia..:

Kokkotis, G ; Zampeli, E ; Tzouvala, M...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S387-S387 , 2021
Link: https://doi.org/10.1093/..
 
?
7

PCN89 A Cost-Effectiveness Analysis of Atezolizumab in Comb..:

Pinheiro, B. ; Cardoso, M. ; Lourenço, F....
Value in Health.  23 (2020)  - p. S437-S438 , 2020
Link: https://doi.org/10.1016/..
 
?
8

PCN66 Cost-Effectiveness Model Adapted to Italian Clinical ..:

Bellone, M. ; Pradelli, L. ; Gancitano, G..
Value in Health.  23 (2020)  - p. S433 , 2020
Link: https://doi.org/10.1016/..
 
?
9

PCN85 An Updated Cost-Utility Analysis in Italian Patients ..:

Bellone, M. ; Pradelli, L. ; Gancitano, G..
Value in Health.  23 (2020)  - p. S436-S437 , 2020
Link: https://doi.org/10.1016/..
 
?
10

PCN54 Measuring the Economic, Societal, and Organizational ..:

Andre, C. ; Orfanos, P.
Value in Health.  23 (2020)  - p. S431 , 2020
Link: https://doi.org/10.1016/..
 
?
11

PCN148 COST-UTILITY OF ENTRECTINIB VERSUS CRIZOTINIB IN ROS..:

Bellone, M. ; Zaniolo, O. ; Martinelli, E....
Value in Health.  22 (2019)  - p. S464 , 2019
Link: https://doi.org/10.1016/..
 
?
12

RW2 METHODOLOGICAL APPROACHES FOR INCORPORATING REAL-WORLD ..:

Connor, S. ; Orfanos, P. ; Flahavan, E...
Value in Health.  22 (2019)  - p. S921 , 2019
Link: https://doi.org/10.1016/..
 
?
13

PRO114 EQ-5D UTILITY ESTIMATES FOR PATIENTS WITH SYSTEMIC S..:

Orfanos, P. ; Felizzi, F. ; Thuresson, P.O.
Value in Health.  22 (2019)  - p. S862 , 2019
Link: https://doi.org/10.1016/..
 
?
14

PCN147 ENTRECTINIB IN NTRK TUMOR AGNOSTIC INDICATION COMPAR..:

Bellone, M. ; Zaniolo, O. ; Martinelli, E....
Value in Health.  22 (2019)  - p. S464 , 2019
Link: https://doi.org/10.1016/..
 
?
15

PCN94 CHALLENGES AND AN APPROACH TO PERFORMING COST-EFFECTI..:

Orfanos, P. ; Wong, W. ; Bennett, I.
Value in Health.  22 (2019)  - p. S73 , 2019
Link: https://doi.org/10.1016/..
 
1-15